We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




“Social Media Network” for the Chronically Ill

By HospiMedica International staff writers
Posted on 26 Mar 2013
Print article
A mobile and web platform for patients with chronic conditions offers data consolidation among a variety of patient monitoring devices.

The Wellaho Personalized Outpatient Management System assists the collection of physiological data, such as blood pressure, blood sugar levels, and patient vital signs, from outpatients being treated for cancer and other chronic diseases. Physician-directed, web-based, and mobile platforms allow providers to supervise and monitor patients between office visits in a secure, Health Insurance Portability and Accountability Act (HIPAA) compliant environment, while enabling patients to access their medical information, monitor their condition, stream relevant educational materials, and connect securely to their doctors and healthcare team.

The system maintains patient data on a secure data storage server that can be accessed by the patient, the patient’s doctors, and certain other health care providers. It also enables patients to provide daily personal updates about their own health status to describe their relative fatigue, pain level, mood, and how well they are eating. Patients also access medical information about their own health, monitor their condition, get relevant educational information, and to communicate with their doctors and healthcare team. The Wellaho system is a product of Sanitas (San Diego, CA, USA), and has been approved by the US food and drug Administration (FDA).

“Given the tsunami of new apps and technologies that hit the market each year, both patients and providers need the highest validation for the products and services they use,” said Naser Partovi, CEO of Sanitas. “Wellaho offers one more reason for providers and patients to trust that we can provide a safe, secure, and effective solution for managing their care.”

Related Links:

Sanitas


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
AI-Enabled EEG Analysis Software
autoSCORE
New
Neonatal Open Care Warmer
Babyroo TN300

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.